Merck
Impact of Synthia on GSK Chemical Development
The webinar focused on the advancements in SYNTHIA™ Retrosynthesis Software and its impact on chemical development at GlaxoSmithKline (GSK), presented by John Lim from GSK. John highlighted how SYNTHIA™ has become an integral tool in GSK's chemical development process, aiding in route selection and synthesis planning. The software's ability to suggest diverse, high-quality synthetic routes has enhanced GSK's confidence in their chosen pathways...
John Lim
Senior Scientist API Chemistry, GSK Chemical Development
Dr. Ewa Gajewska
Head of Product Management
Register for webinar
John Lim, Dr. Ewa Gajewska
Impact of Synthia on GSK Chemical Development
Topics
Webinars on related topics
Products on related topics
White papers on related topics
More webinars from Merck
More webinars on similar topics
See the theme worlds for related content
Topic world Digitalization in the laboratory
The topic world Digitalization in the lab presents innovations and trends from digital data systems (ELN, LIMS) to laboratory robots and networked devices (IoT) to AI and machine learning.
Topic world Digitalization in the laboratory
The topic world Digitalization in the lab presents innovations and trends from digital data systems (ELN, LIMS) to laboratory robots and networked devices (IoT) to AI and machine learning.
